Analyst Ratings for Biogen (BIIB)

BIIB Rating Summary

BIIB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BIIB
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $265.92 (+25.5%) * Over Last 12-Mos
Rating Score: 4.8 / 10   Percentile Rank: 44%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/18/2022 Wells Fargo Mohit Bansal Upgrade Overweight
(Equal Weight)
265.00
(N/A)
212.55
(211.93)
-0.29% Details
3/8/2022 Stifel
» Updated 5/3/2022
Paul Matteis Downgrade Hold
(Buy)
230.00
(N/A)
209.45
(211.93)
1.18% Details
Like BIIB Ratings? Also take a look at IONS, SAGE, EDU, FENC

BIIB Ratings News